Egis invests HUF 8 bln in expanding production capacity
Drugmaker Egis, majority owned by Franceʼs Servier, is investing HUF 8 billion at its base in Körmend in western Hungary, the company said on Tuesday. The government is providing a HUF 1.1 bln grant towards the investment, said Minister of Foreign Affairs and Trade Péter Szijjártó.
The company is investing in expanding its production capacity because of an increase in turnover, Egis CEO István Hodász was cited as saying by state news agency MTI.
The company will build a packaging plant and upgrade the facility to allow the production of new oncological products and medicines.
Egis expects to increase its export sales, Hodász added. Egis exports around 75% of its products, and has sales in more than 50 countries.
ADVERTISEMENT
POPIHN Raises Forecast for Fuel Consumption
Hungarian Lawmakers Ratify Finland's NATO Accession
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
